1. Home
  2. DXCM vs HAL Comparison

DXCM vs HAL Comparison

Compare DXCM & HAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • HAL
  • Stock Information
  • Founded
  • DXCM 1999
  • HAL 1919
  • Country
  • DXCM United States
  • HAL United States
  • Employees
  • DXCM N/A
  • HAL N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • HAL Oilfield Services/Equipment
  • Sector
  • DXCM Health Care
  • HAL Energy
  • Exchange
  • DXCM Nasdaq
  • HAL Nasdaq
  • Market Cap
  • DXCM 34.1B
  • HAL 18.0B
  • IPO Year
  • DXCM 2005
  • HAL N/A
  • Fundamental
  • Price
  • DXCM $85.15
  • HAL $21.97
  • Analyst Decision
  • DXCM Strong Buy
  • HAL Strong Buy
  • Analyst Count
  • DXCM 20
  • HAL 18
  • Target Price
  • DXCM $98.50
  • HAL $33.11
  • AVG Volume (30 Days)
  • DXCM 3.8M
  • HAL 16.1M
  • Earning Date
  • DXCM 07-30-2025
  • HAL 07-22-2025
  • Dividend Yield
  • DXCM N/A
  • HAL 2.95%
  • EPS Growth
  • DXCM N/A
  • HAL N/A
  • EPS
  • DXCM 1.33
  • HAL 2.40
  • Revenue
  • DXCM $4,148,000,000.00
  • HAL $22,557,000,000.00
  • Revenue This Year
  • DXCM $16.74
  • HAL N/A
  • Revenue Next Year
  • DXCM $15.29
  • HAL $0.92
  • P/E Ratio
  • DXCM $62.58
  • HAL $9.63
  • Revenue Growth
  • DXCM 9.11
  • HAL N/A
  • 52 Week Low
  • DXCM $57.52
  • HAL $18.72
  • 52 Week High
  • DXCM $117.19
  • HAL $37.08
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 49.26
  • HAL 61.43
  • Support Level
  • DXCM $82.73
  • HAL $21.66
  • Resistance Level
  • DXCM $85.92
  • HAL $22.40
  • Average True Range (ATR)
  • DXCM 2.63
  • HAL 0.83
  • MACD
  • DXCM -0.09
  • HAL 0.14
  • Stochastic Oscillator
  • DXCM 54.33
  • HAL 91.60

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About HAL Halliburton Company

Halliburton is North America's largest oilfield service company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. The firm's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been homed in over a century of operations.

Share on Social Networks: